Search icon

SOUTH FLORIDA VETERANS AFFAIRS FOUNDATION FOR RESEARCH AND EDUCATION, INC. - Florida Company Profile

Company claim

Is this your business?

Get access!

Company Details

Entity Name: SOUTH FLORIDA VETERANS AFFAIRS FOUNDATION FOR RESEARCH AND EDUCATION, INC.
Jurisdiction: FLORIDA
Filing Type: Domestic Non-Profit
Status: Active

The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness.

Date Filed: 21 May 1990 (35 years ago)
Last Event: AMENDED AND RESTATED ARTICLES
Event Date Filed: 19 Mar 2014 (11 years ago)
Document Number: N38239
FEI/EIN Number 650207903

Federal Employer Identification (FEI) Number assigned by the IRS.

Address: 1201 N.W. 16TH STREET ROOM D806, MIAMI, FL, 33125, US
Mail Address: 1201 N.W. 16TH STREET ROOM D806, MIAMI, FL, 33125, US
ZIP code: 33125
City: Miami
County: Miami-Dade
Place of Formation: FLORIDA

Key Officers & Management

Name Role Address
JACKSON ROBERT MM.D. President 1201 N.W. 16TH STREET, MIAMI, FL, 33125
SPECTOR SETH M.D. STAT 1201 N.W. 16TH STREET, MIAMI, FL, 33125
WASHBURN KATRINA BPhd Executive 1201 N.W. 16TH STREET, MIAMI, FL, 33125
JangDhari Kalautie SM.D. STAT 1201 N.W. 16TH STREET, MIAMI, FL, 33125
COOKE TIMOTHY JFACHE STAT 13800 VETERANS WAY, ORLANDO, FL, 32827
HAGENLOCKER BRIAN MMD STAT 1201 N.W. 16TH STREET, MIAMI, FL, 33125
JACKSON ROBERT MM.D. Agent 1201 N.W. 16TH STREET ROOM 2A103, MIAMI, FL, 33125

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
T6R1YQK65LJ3
CAGE Code:
54RX6
UEI Expiration Date:
2025-07-25

Business Information

Doing Business As:
SOUTH FLORIDA VETERANS AFFAIRS FOUNDATION FOR RESEARCH & EDUCATION
Activation Date:
2024-07-29
Initial Registration Date:
2008-07-09

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
54RX6
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2025-07-09
CAGE Expiration:
2030-07-09
SAM Expiration:
2026-07-08

Contact Information

POC:
KATRINA WASHBURN
Corporate URL:
http://www.sfvafre.org/

Form 5500 Series

Employer Identification Number (EIN):
650207903
Plan Year:
2023
Number Of Participants:
28
Sponsors Telephone Number:
Plan Year:
2022
Number Of Participants:
35
Sponsors Telephone Number:
Plan Year:
2021
Number Of Participants:
34
Sponsors Telephone Number:
Plan Year:
2020
Number Of Participants:
34
Sponsors Telephone Number:
Plan Year:
2019
Number Of Participants:
37
Sponsors Telephone Number:

Fictitious Names

Registration Number Fictitious Name Status Filed Date Expiration Date Cancellation Date Mailing Address
G12000004933 SOUTH FLORIDA VA FOUNDATION FOR RESEARCH AND EDUCATION, INC. D/B/A ROBERT RONIS MEMORIAL IPF FUND ACTIVE 2012-01-13 2027-12-31 - 1201 NW 16TH STREET, D806, MIAMI, FL, 33125

Events

Event Type Filed Date Value Description
CHANGE OF PRINCIPAL ADDRESS 2017-01-10 1201 N.W. 16TH STREET ROOM D806, MIAMI, FL 33125 -
CHANGE OF MAILING ADDRESS 2017-01-10 1201 N.W. 16TH STREET ROOM D806, MIAMI, FL 33125 -
REGISTERED AGENT ADDRESS CHANGED 2017-01-10 1201 N.W. 16TH STREET ROOM 2A103, MIAMI, FL 33125 -
AMENDED AND RESTATEDARTICLES 2014-03-19 - -
REGISTERED AGENT NAME CHANGED 2011-03-29 JACKSON, ROBERT M, M.D. -
AMENDMENT 1990-10-11 - -

Documents

Name Date
ANNUAL REPORT 2024-02-07
ANNUAL REPORT 2023-01-20
ANNUAL REPORT 2022-01-26
ANNUAL REPORT 2021-02-01
ANNUAL REPORT 2020-01-15
ANNUAL REPORT 2019-02-13
ANNUAL REPORT 2018-01-16
ANNUAL REPORT 2017-01-10
ANNUAL REPORT 2016-02-29
ANNUAL REPORT 2015-04-02

USAspending Awards / Contracts

Procurement Instrument Identifier:
V546D05046
Award Or Idv Flag:
AWARD
Award Type:
PO
Action Obligation:
23600.91
Base And Exercised Options Value:
23600.91
Base And All Options Value:
23600.91
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2010-09-01
Description:
MEDICAL SUPPLIES
Naics Code:
541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product Or Service Code:
AJ52: LIFE SCIENCES (APPLIED/EXPLORATORY)
Procurement Instrument Identifier:
VA546D05046
Award Or Idv Flag:
AWARD
Award Type:
PO
Action Obligation:
23600.91
Base And Exercised Options Value:
23600.91
Base And All Options Value:
23601.90
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2010-09-01
Description:
CLINICAL LABORATORY RESEARCH SUPPORT INVOLVING SPECIFIC ASSAY REVIEWS IN SUPPORT OF THE MECHANISMS OF ASTROCYTE SWELLING IN ACUTE LIVER FAILURE PROJECT.
Naics Code:
541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product Or Service Code:
C118: RESEARCH AND DEVELOPMENT FACILITIES
Procurement Instrument Identifier:
V546D05042
Award Or Idv Flag:
AWARD
Award Type:
PO
Action Obligation:
14101.09
Base And Exercised Options Value:
14101.09
Base And All Options Value:
14101.09
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2010-08-05
Description:
TAS::36 0161::TAS MEDICAL SERVICES
Product Or Service Code:
Q518: PHYSICAL MEDICINE & REHABILITATION

USAspending Awards / Financial Assistance

Date:
2021-01-19
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
A NEW STRATEGY TO INCREASE PROTEOTOXIC CELL DEATH IN HEPATOCELLULAR CARCINOMA - INHIBITORS OF THE UBIQUITIN PROTEASOME SYSTEM (UPS, THE MAJOR PATHWAY THAT DEGRADES UNFOLDED PROTEINS) INCREASE PROTEOTOXIC STRESS AND HAVE CLINICAL SUCCESS FOR MULTIPLE MYELOMA BUT NOT FOR SOLID CANCERS SUCH AS HEPATOCELLULAR CARCINOMA (HCC). CURRENT CLINICAL STRATEGIES TO FURTHER ENHANCE PROTEOTOXIC STRESS IN SOLID TUMORS BY COMBINING PAN-HISTONE DEACETYLASE (HDAC) + UPS INHIBITORS HAS SOME SUCCESS BUT COMES WITH HIGH TOXICITY TO NORMAL TISSUES. WE PROPOSE AN ALTERNATIVE STRATEGY TO ENHANCE PROTEOTOXIC STRESS IN HCC BUT WITH LESS TOXICITY TO NON-CANCER CELLS BY COMBINING A NEW PAN-CYCLOPHILIN INHIBITOR CRV431 (CRV) AND A SECOND-GENERATION UPS INHIBITOR IXAZOMIB (IXZ). SINCE CYCLOPHILINS ARE IMPORTANT IN PROTEIN FOLDING, COMBINING A PAN-CYCLOPHILIN INHIBITOR SUCH AS CRV TO INCREASE MISFOLDED PROTEINS AND BLOCKING THEIR DEGRADATION WITH A UPS INHIBITOR SUCH AS IXZ AMPLIFIES PROTEOTOXIC STRESS AND FORCES APOPTOTIC CELL DEATH. OUR PRELIMINARY DATA SUPPORTS THE USE OF CRV + IXZ AS A NEW STRATEGY FOR TREATMENT OF HCC WITHOUT CAUSING TOXICITY TO NON-CANCER CELLS. WE PROPOSE THAT MAINTENANCE OF ELEVATED LEVELS OF PRO-SURVIVAL RESPONSE MEDIATOR XBP1S (UNFOLDED PROTEIN RESPONSE) AND LOW CYCLOPHILIN EXPRESSION/ACTIVITY TRIGGERS CELL DEATH IN HCC CELLS. NOTABLY, CRV + IXZ IS NOT TOXIC IN A NON-CANCER COMPARED TO HCC CELLS WHEREAS A CURRENT PROTEOTOXIC STRESS COMBINATION PANOBINOSTAT (CLINICALLY RELEVANT PAN-HDAC INHIBITOR) + IXZ IS EQUALLY TOXIC IN NON-CANCER AND HCC CELLS. THE HYPOTHESIS OF THIS PROPOSAL IS THAT CRV + IXZ MAINTENANCE OF HIGH XBP1S AND LOW CYCLOPHILIN EXPRESSION/ACTIVITY OVERWHELMS PRO-SURVIVAL PATHWAYS AND FORCES HCC CELLS TOWARD APOPTOTIC CELL DEATH WITHOUT HARMING NORMAL CELLS. THE RATIONALE IS THAT IF THIS NEW COMBINATION KILLS HCC CELLS WITHOUT HARMING NORMAL CELLS IN PRECLINICAL MODELS, THE CHANCES FOR SUCCESS IN CLINICAL SETTINGS WILL INCREASE. AIM 1: IDENTIFY MEDIATORS THAT LINK ACTIVATION OF APOPTOTIC CELL DEATH IN CRV + IXZ TREATED HCC BUT NOT IN NON- CANCER CELLS. AIM 2: INVESTIGATE THE EFFICACY OF THE ORALLY BIOAVAILABLE CRV + IXZ COMBINATION IN MOUSE MODELS OF HCC. IN ADVANCED HCC, THERE HAS BEEN LITTLE PROGRESS IN DISCOVERING NEW CHEMOTHERAPY STRATEGIES. WE PROPOSE THAT TARGETING THE ESSENTIAL PROTEOTOXIC STRESS RESPONSE SURVIVAL PATHWAY BY COMBINING ORALLY BIOAVAILABLE PAN-CYCLOPHILIN AND UPS INHIBITORS WILL BE A USEFUL STRATEGY TO SELECTIVELY KILL HCC WITHOUT CAUSING EXCESSIVE SIDE EFFECTS TO NORMAL TISSUES. CURRENTLY, CRV IS BEING INVESTIGATED AS AN ANTI-VIRAL AND ANTI-LIVER FIBROSIS AGENT AND WE ARE THE FIRST TO PROPOSE ITS USE IN HCC COMBINATION THERAPY. THE LONG-TERM GOAL WILL BE TO USE CRV + IXZ TO TREAT HCC PATIENTS WITH THE HOPE THAT PROTEOTOXIC STRESS CELL DEATH SPECIFICALLY IN HCC CELLS WITHOUT CAUSING TOXICITY TO NORMAL TISSUES WILL INCREASE OVERALL SURVIVAL AND IMPROVE QUALITY OF LIFE.
Obligated Amount:
127200.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2023-09-19
Awarding Agency Name:
Department of Defense
Transaction Description:
GULF WAR ILLNESS: EXPLORING THE EYE-BRAIN CONNECTION EXTEND THE PERIOD OF PERFORMANCE AND REMOVE PAYMENT RESTRICTION HRPO APPROVAL 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA), US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC) TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022. THIS MODIFICATION REFLECTS CHANGES CONSISTENT WITH THE TRANSFER TO DHA. 2. DIVISION II HAS BEEN UPDATED TO SUPERSEDE DIVISION III, PART 2, SECTION C, 2.B. ELECTRONIC PAYMENT INSTRUCTIONS
Obligated Amount:
0.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-07-22
Awarding Agency Name:
Department of Defense
Transaction Description:
GULF WAR ILLNESS: EXPLORING THE EYE-BRAIN CONNECTION
Obligated Amount:
622435.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2017-09-28
Awarding Agency Name:
Department of Defense
Transaction Description:
MEASUREMENT OF BIOMARKERS IN SAMPLES COLLECTED IN A COENZYME Q10 TREATMENT TRIAL IN GULF WAR ILLNESS AND CONTROL SUBJECTS
Obligated Amount:
690584.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2017-09-28
Awarding Agency Name:
Department of Defense
Transaction Description:
MEASUREMENT OF BIOMARKERS IN SAMPLES COLLECTED IN A COENZYME Q10 TREATMENT TRIAL IN GULF WAR ILLNESS AND CONTROL SUBJECTS
Obligated Amount:
326854.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 03 Jul 2025

Sources: Florida Department of State